Literature DB >> 16393227

Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy.

Walter Fries1, Maria C Renda, Maria A Lo Presti, Antonella Raso, Ambrogio Orlando, Lorenzo Oliva, Maria R Giofré, Aurelio Maggio, Anna Mattaliano, Alfredo Macaluso, Mario Cottone.   

Abstract

OBJECTIVE: A defect of gastrointestinal barrier function is considered to represent an important step in the pathogenesis of Crohn's disease (CD) but the mechanisms leading to an increased intestinal permeability (IP) are poorly understood. Since IP is influenced by pro-inflammatory mediators, it seems likely that a genetically determined abnormal immune response may lead to a loss of barrier function.
METHODS: In a geographic area in Southern Italy with high incidence of CD we investigated IP (lactulose/mannitol testing) together with the three main mutations of the NOD2/CARD15 and the D299G polymorphism of the toll-like receptor (TLR)-4 gene in 23 families of CD patients (patients and first-degree relatives).
RESULTS: Forty-eight percent of CD patients and 40% of their healthy relatives were found to have an abnormal IP compared to 5% of an appropriate control population (p < 0.0001). IP, however, was not associated with the L1007finsC mutation of the NOD2/CARD15 or the D299G variant of the TLR-4 gene. Allele frequency of the only L1007finsC mutation of CARD15 was significantly increased in patients (8.7%, p < 0.003) and in relatives (8.3%, p < 0.024) compared with controls (2.4%), whereas the D299G variant of the TLR-4 gene was found to be increased only in relatives (8.3%, p < 0.022), but not in patients (4.3%) compared with the control population (1.7%).
CONCLUSIONS: There was no association between IP and genetic markers. Our findings showed a very high proportion of healthy first-degree relatives to bare alterations suggested to constitute determinants of CD. Mutations of NOD2/CARD15 or TLR-4, however, do not lead to permeability defects emphasizing the importance of additional environmental and/or genetic factors for pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16393227     DOI: 10.1111/j.1572-0241.2005.00325.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  29 in total

1.  Enterocytes' tight junctions: From molecules to diseases.

Authors:  Stelios F Assimakopoulos; Ismini Papageorgiou; Aristidis Charonis
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

Review 2.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

3.  Controversies about the use of serological markers in diagnosis of inflammatory bowel disease.

Authors:  Qin Xie; Hua-Tian Gan
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

4.  Erythrocyte deformability and oxidative stress in inflammatory bowel disease.

Authors:  Tulay Akman; Mesut Akarsu; Hale Akpinar; Halil Resmi; Ebru Taylan; Ebru Sezer
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

Review 5.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

6.  Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation.

Authors:  Rocío López-Posadas; Christoph Becker; Claudia Günther; Stefan Tenzer; Kerstin Amann; Ulrike Billmeier; Raja Atreya; Gionata Fiorino; Stefania Vetrano; Silvio Danese; Arif B Ekici; Stefan Wirtz; Veronika Thonn; Alastair J M Watson; Cord Brakebusch; Martin Bergö; Markus F Neurath; Imke Atreya
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

Review 7.  Mucosal healing and deep remission: what does it mean?

Authors:  Gerhard Rogler; Stephan Vavricka; Alain Schoepfer; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Effects of timing, sex, and age on site-specific gastrointestinal permeability testing in children and adults.

Authors:  Mark E McOmber; Ching-Nan Ou; Robert J Shulman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-03       Impact factor: 2.839

9.  Readressing the role of Toll-like receptor-4 alleles in inflammatory bowel disease: colitis, smoking, and seroreactivity.

Authors:  Anastassios C Manolakis; Andreas N Kapsoritakis; Anastasia Kapsoritaki; Elisavet K Tiaka; Konstantinos A Oikonomou; Vassilis Lotis; Dimitra Vamvakopoulou; Ioanna Davidi; Nikolaos Vamvakopoulos; Spyros P Potamianos
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

10.  Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.

Authors:  Luciana Rigoli; Claudio Romano; Rosario Alberto Caruso; Maria A Lo Presti; Chiara Di Bella; Vincenzo Procopio; Giuseppina Lo Giudice; Maria Amorini; Giuseppe Costantino; Maria D Sergi; Caterina Cuppari; Giovanna Elisa Calabro; Romina Gallizzi; Carmelo Damiano Salpietro; Walter Fries
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.